The stratified analysis based on Cbx4 or VEGF expression level showed that TAE and TACE treatment had no effect on the OS of patients with HCC tumors of low Cbx4 or VEGF expression (Figure 3a). The gene discussed is CBX4; the disease is hepatocellular carcinoma.